Position in AKBA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$43,967
+$677 QoQ
Shares Held
38,568
+23.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#15
of 53 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AKBA Over Time
Shares Held
Position Value (USD)
Derivatives in AKBA
reported options exposure · as of Sep 30, 2020CallValue
$7,530
CallShares
3,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $47,963,007 across 28 Drug Manufacturers - Specialty & Generic names. AKBA ranks #27 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
253,412 | $18,210,186 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
205,600 | $6,965,728 | |
| 3 | INDV |
Indivior Pharmaceuticals, Inc.
|
83,088 | $3,409,100 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
4,008 | $2,171,654 | |
| 5 | VTRS |
Viatris Inc
|
130,959 | $2,079,628 | |
| 6 | ETON |
Eton Pharmaceuticals, Inc.
|
52,907 | $1,915,233 | |
| 7 | TRLV |
Trulieve Cannabis Corp.
|
156,492 | $1,538,316 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
95,466 | $1,530,319 |
All Filings in AKBA
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $43,967 | 38,568 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $43,290 | 31,144 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $43,872 | 27,250 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $319,683 | 117,100 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $426,244 | 117,100 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $242,112 | 126,100 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $177,365 | 93,350 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $123,222 | 93,350 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $90,117 | 88,350 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $134,230 | 73,350 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $119,474 | 96,350 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $108,699 | 95,350 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $64,370 | 70,350 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $39,396 | 70,350 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $34,288 | 59,425 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $16,439 | 52,024 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $16,140 | 45,724 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $34,953 | 48,682 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $110,046 | 48,693 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $140,235 | 48,693 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $186,251 | 49,143 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $166,349 | 49,143 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $138,558 | 49,485 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $7,530 | 3,000 | Call | Sole | 2020-11-13 | |
| 2020-09-30 | $130,612 | 52,037 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $492,356 | 36,256 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $271,409 | 35,806 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||